English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, March 30, 2023
欧康维视公布2022年全年业绩
歐康維視公佈2022年全年業績
Ocumension Therapeutics Announces 2022 Annual Results
Monday, March 13, 2023
欧康维视获纳入沪港通及深港通名单
歐康維視獲納入滬港通及深港通名單
Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs
Tuesday, February 14, 2023
欧康维视发布2022年度业绩盈利预喜
歐康維視發佈2022年度業績盈利預喜
Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results
Friday, February 3, 2023
欧康维视研发的治疗干眼症的I类新药OT-202 I期临床试验完成

Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575